Anastos K - Search Results

1

Gut microbiota, circulating inflammatory markers and metabolites, and carotid artery atherosclerosis in HIV infection.

Wang Z, Peters BA, Bryant M, Hanna DB, Schwartz T, Wang T, Sollecito CC, Usyk M, Grassi E, Wiek F, Peter LS, Post WS, Landay AL, Hodis HN, Weber KM, French A, Golub ET, Lazar J, Gustafson D, Sharma A, Anastos K, Clish CB, Burk RD, Kaplan RC, Knight R, Qi Q. Wang Z, et al. Among authors: anastos k. Microbiome. 2023 May 27;11(1):119. doi: 10.1186/s40168-023-01566-2. Microbiome. 2023. PMID: 37237391 Free PMC article.

2

Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group.

Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, Burns D, Greenblatt RM, Muderspach LI, Miotti P. Massad LS, et al. Among authors: anastos km. J Acquir Immune Defic Syndr. 1999 May 1;21(1):33-41. doi: 10.1097/00126334-199905010-00005. J Acquir Immune Defic Syndr. 1999. PMID: 10235512

3

Vitamin A deficiency and genital viral burden in women infected with HIV-1.

French AL, Cohen MH, Gange SJ, Burger H, Gao W, Semba RD, Meyer WA 3rd, Robison E, Anastos K. French AL, et al. Among authors: anastos k. Lancet. 2002 Apr 6;359(9313):1210-2. doi: 10.1016/S0140-6736(02)08226-0. Lancet. 2002. PMID: 11955543

4

Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study.

Kirstein LM, Greenblatt RM, Anastos K, Levine A, French AL, Minkoff H, Silver S, Gange SJ; Women's Interagency HIV Study Collaborative Research Group. Kirstein LM, et al. Among authors: anastos k. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):495-503. doi: 10.1097/00126334-200204150-00010. J Acquir Immune Defic Syndr. 2002. PMID: 11981366

5

Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy.

Cohen MH, French AL, Benning L, Kovacs A, Anastos K, Young M, Minkoff H, Hessol NA. Cohen MH, et al. Among authors: anastos k. Am J Med. 2002 Aug 1;113(2):91-8. doi: 10.1016/s0002-9343(02)01169-5. Am J Med. 2002. PMID: 12133746 Free PMC article.

6

The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts.

Silverberg MJ, Ahdieh L, Munoz A, Anastos K, Burk RD, Cu-Uvin S, Duerr A, Greenblatt RM, Klein RS, Massad S, Minkoff H, Muderspach L, Palefsky J, Piessens E, Schuman P, Watts H, Shah KV. Silverberg MJ, et al. Among authors: anastos k. Sex Transm Dis. 2002 Aug;29(8):427-35. doi: 10.1097/00007435-200208000-00001. Sex Transm Dis. 2002. PMID: 12172526

7

Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection.

Falusi O, French AL, Seaberg EC, Tien PC, Watts DH, Minkoff H, Piessens E, Kovacs A, Anastos K, Cohen MH. Falusi O, et al. Among authors: anastos k. Clin Infect Dis. 2002 Dec 1;35(11):1414-7. doi: 10.1086/344462. Epub 2002 Nov 11. Clin Infect Dis. 2002. PMID: 12439806 Free PMC article.

8

Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.

Viscidi RP, Ahdieh-Grant L, Clayman B, Fox K, Massad LS, Cu-Uvin S, Shah KV, Anastos KM, Squires KE, Duerr A, Jamieson DJ, Burk RD, Klein RS, Minkoff H, Palefsky J, Strickler H, Schuman P, Piessens E, Miotti P. Viscidi RP, et al. Among authors: anastos km. J Infect Dis. 2003 Jan 15;187(2):194-205. doi: 10.1086/346052. Epub 2003 Jan 6. J Infect Dis. 2003. PMID: 12552444

9

Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.

Viscidi RP, Ahdieh-Grant L, Schneider MF, Clayman B, Massad LS, Anastos KM, Burk RD, Minkoff H, Palefsky J, Levine A, Strickler H. Viscidi RP, et al. J Infect Dis. 2003 Dec 15;188(12):1834-44. doi: 10.1086/379975. Epub 2003 Dec 5. J Infect Dis. 2003. PMID: 14673762

10

Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy.

Anastos K, Shi Q, French AL, Levine A, Greenblatt RM, Williams C, DeHovitz J, Delapenha R, Hoover DR. Anastos K, et al. J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):383-92. doi: 10.1097/00126334-200404010-00008. J Acquir Immune Defic Syndr. 2004. PMID: 15097155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

512 results

Search Page